TYPE III HYPERLIPIDAEMIA

This adverse event was reported 7 times

TYPE III HYPERLIPIDAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CLOMIPHENE CITRATE 1 0.0007
1 EFAVIRENZ 4 0.0004
2 TENOFOVIR DISOPROXIL FUMARATE TABLETS 2 0.0002
3 LAMIVUDINE 4 0.0002
4 CARBAMAZEPINE 1 0.0000
5 USTEKINUMAB 1 0.0000
6 CLONAZEPAM 1 0.0000
See all drugs enriched for association with TYPE III HYPERLIPIDAEMIA